Validation of novel grading schemes and refinement of the Leibovich risk groups for chromophobe renal cell carcinoma

被引：0

作者：

Haiyue Lin ^{[1
]}

Caiying Wang ^{[2
]}

Yun Zhao ^{[3
]}

Run Wang ^{[4
]}

Wei Xi ^{[5
]}

Ying Xiong ^{[5
]}

Li Xiao ^{[3
]}

Yi Liu ^{[1
]}

Shaoting Zhang ^{[6
]}

Chenchen Dai ^{[7
]}

机构：

[1] Xuzhou Medical University Affiliated Hospital of Lianyungang,Department of Pathology

[2] Fudan University,Department of Pathology, Zhongshan Hospital

[3] Fudan University,Department of Pathology, Huadong Hospital

[4] Sir Run Run Shaw Hospital,Department of Pathology

[5] Fudan University,Department of Urology, Zhongshan Hospital

[6] Shandong Cancer Hospital and Institute,Department of Radiology

[7] Shandong First Medical University,Department of Radiology, Zhongshan Hospital

[8] Shandong Academy of Medical Sciences,undefined

[9] Fudan University,undefined

来源：

World Journal of Urology | / 43卷 / 1期

关键词：

Chromophobe renal cell carcinoma; Prognosis; Grading schemes; Leibovich risk groups;

D O I：

10.1007/s00345-024-05394-3

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Grading Challenges and Prognostic Insights in Chromophobe Renal Cell Carcinoma: A Retrospective Study of 72 Patients
Papanikolaou, Dimitrios
Sokolakis, Ioannis
Moysidis, Kyriakos
Pyrgidis, Nikolaos
Bobos, Mattheos
Meditskou, Soultana
Hatzimouratidis, Konstantinos
MEDICINA-LITHUANIA, 2024, 60 (06):
[32] The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinoma
Steffens, Sandra
Janssen, Martin
Roos, Frederik C.
Becker, Frank
Steinestel, Julie
Abbas, Mahmoud
Steinestel, Konrad
Wegener, Gerd
Siemer, Stefan
Thueroff, Joachim W.
Hofmann, Rainer
Stoeckle, Michael
Schrader, Mark
Hartmann, Arndt
Hasenfus, Andrea
Kuczyk, Markus A.
Junker, Kerstin
Schrader, Andres J.
HUMAN PATHOLOGY, 2014, 45 (12) : 2411 - 2416
[33] KAI1 is a novel biomarker for chromophobe renal cell carcinoma
Kauffman, Eric C.
Barocas, Daniel A.
Yang, Ximing J.
Liu, Huixian
Scherr, Douglas S.
Tu, Jiangliang J.
JOURNAL OF UROLOGY, 2008, 179 (04): : 134 - 134
[34] Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates
Reza Alaghehbandan
Christopher GPrzybycin
Virginie Verkarre
Rohit Mehra
Asian Journal of Urology, 2022, (01) : 1 - 11
[35] External validation of the updated Leibovich prognostic models for clear cell and papillary renal cell carcinoma in an Asian population
Lee, Han Jie
Lee, Alvin
Huang, Hong Hong
Lau, Weber Kam On
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (06) : 356.e9 - 356.e18
[36] Chromophobe renal cell carcinoma presenting as a renal cyst
Bellalah, A.
Mabrouk, S.
Ben Abdeljelil, N.
Chebaane, C.
Njim, L.
Hadhri, R.
Zakhama, A.
Njima, M.
VIRCHOWS ARCHIV, 2021, 479 : S311 - S311
[37] Multicenter evaluation of CT deep radiomics model in predicting Leibovich score risk groups for non-metastatic clear cell renal cell carcinoma
Li, Wuchao
Yang, Tongyin
Li, Pinhao
Liu, Xinfeng
Zhang, Shasha
Zhu, Jianguo
Pei, Yuanyuan
Zhang, Yan
Zhang, Tijiang
Wang, Rongpin
DISPLAYS, 2024, 85
[38] Application and comparison of Fuhrman nuclear grading system with the novel tumor grading system for chromophobe renal cell carcinoma and its correlation with disease-specific events
Sali, Akash Pramod
Bahirwade, Ganesh K.
Bakshi, Ganesh
Prakash, Gagan
Joshi, Amit
Desai, Sangeeta B.
Menon, Santosh
INDIAN JOURNAL OF UROLOGY, 2021, 37 (02) : 147 - 152
[39] Imprint Cytologic Features of Chromophobe Renal Cell Carcinoma Morphologically Resembling Renal Oncocytoma: Is This an Oncocytic Variant of Chromophobe Renal Cell Carcinoma?
Yamaguchi, Tadanori
Kuroda, Naoto
Imamura, Yoshiaki
Hes, Ondrej
Michal, Michal
Sima, Radek
Nakayama, Keizou
Sato, Nodoka
DIAGNOSTIC CYTOPATHOLOGY, 2010, 38 (07) : 509 - 513
[40] Synchronous bilateral chromophobe cell renal carcinoma
Yakout, HH
Bissada, NK
Fahmy, W
Creasman, W
Fraig, M
Hull, GW
JOURNAL OF UROLOGY, 2001, 166 (05): : 1826 - 1826

← 1 2 3 4 5 →